CMS Recalculates Medicare Advantage Star Ratings, Injecting New Volatility into the System

Introduction

The Centers for Medicare & Medicaid Services (CMS) has initiated another recalibration of the star ratings system for Medicare Advantage plans, a decision that is already rippling through the U.S. healthcare landscape. Star ratings are a central performance measure used by CMS to determine not only the quality of Medicare Advantage plans, but also the bonus payments these plans receive—payments that have reportedly ballooned to a striking $16 billion this year. The process for calculating these ratings has become a flashpoint of volatility, adding new fiscal and operational uncertainty to participants across the market.

Medicare Advantage, the privatized form of Medicare, has grown to cover over half of eligible U.S. seniors, making the stakes for these ratings exceptionally high. For plans receiving four out of five stars or higher, CMS awards bonus payments, incentivizing strong performance on a suite of clinical and consumer-focused measures. Yet, how these ratings are calculated and recalibrated has become a matter of significant controversy, legal wrangling, and industry challenge—especially as billions of dollars hang in the balance.

In this in-depth analysis, we examine:

• The implications of the latest recalculation for insurers, providers, and beneficiaries
• Ongoing lawsuits and legal questions about CMS’s star ratings methodology
• Potential impacts on plan design, member access, and provider incentives
• Broader policy implications for Medicare Advantage reform

How Star Ratings Shape the U.S. Medicare Advantage Market

CMS’s star ratings serve multiple functions. At their heart, they are designed to:

• Help consumers choose among hundreds of different plans by signaling which deliver the highest quality of care
• Motivate health insurers and providers to meet or exceed performance benchmarks tied to clinical process, outcome, and patient-experience metrics
• Direct federal finances—through substantial bonus payments—toward plans that successfully meet these standards

Plans scoring at least four stars out of five qualify for these financial rewards. In recent years, these bonus payments have grown dramatically, heightening the importance of each percentage point in the overall star rating. The criteria encompass a wide array of measures, including:

• Preventive care delivery (such as immunizations)
• Chronic condition management (like diabetes or hypertension)
• Hospital admission and readmission rates
• Member experience and satisfaction scores

With hundreds of plans targeting the same pool of bonus dollars, the annual recalibration has become a contentious process—especially as tweaks and methodological shifts can trigger substantial revenue swings.

The New Recalculation: Heightened Volatility and Legal Backlash

Reports from industry sources and regulatory filings highlight that the latest recalculation has increased volatility within the program. Some plans find themselves with upgraded ratings (and thus higher bonus eligibility), while others face dramatic downgrades—often with little clarity or forewarning about the underlying changes.

This unpredictability has drawn fierce criticism. Health insurers argue that sudden recalibrations threaten the sustainability of benefit offerings, disrupt contracts with care providers, and may ultimately compromise patient access to quality care. Several leading Medicare Advantage organizations have launched lawsuits challenging CMS’s process, asserting that:

• The system lacks transparency and reliability
• Methodological changes are implemented without sufficient notice or rationale
• Financial and operational consequences are unduly severe given the fast-changing criteria

These ongoing court cases cast a long shadow over the regulatory landscape, with federal judges and CMS officials now closely scrutinizing both the process and the impact of these recalibrations.

Industry Impacts: Plans, Providers, and Policy

The latest recalibration affects all stakeholders in the Medicare Advantage ecosystem:

Insurance Plans

• Plans that drop below four stars may immediately lose eligibility for lucrative CMS bonuses, undercutting their ability to maintain or expand benefits for members
• Sudden downgrades can also fuel member churn as plan quality rankings drop in marketing materials and federal dashboards
• Upside volatility, meanwhile, may incentivize short-term strategies and benefit expansions that could themselves become unsustainable if ratings are further revised

Providers

• Provider groups aligned with high-performing plans stand to lose financial rewards when star ratings drop, affecting care delivery models, staffing, and investment plans
• Uncertainty about future reimbursement complicates long-term care partnerships and value-based payment contracts

Beneficiaries

• Changes in plan quality rankings could translate to abrupt benefit redesigns, higher out-of-pocket costs, or reduced access to supplemental services for millions of seniors
• The credibility and usability of the star rating system as a consumer-facing tool is undermined by year-to-year instability

Legal and Policy Dimensions

The legal challenges to CMS’s recalibration are accelerating. Industry plaintiffs argue that regulatory changes must abide by the Administrative Procedure Act, demanding transparent rationale, stakeholder input, and measured implementation. CMS, for its part, states that regular recalibration and ongoing improvement of the star system is necessary to reflect the evolving healthcare environment and prevent stagnation or manipulation of quality benchmarks.

In Washington, the volatility has catalyzed bipartisan conversation about broader Medicare Advantage reforms. Lawmakers and regulators are weighing:

• Whether CMS should slow the pace of methodological changes
• If greater transparency and stakeholder engagement are needed in rewriting the star methodology
• How to better align short-term bonuses with longer-term improvements in quality and access

Outlook: Uncertainty and Opportunity

With bonus payments now exceeding $16 billion in 2026 alone, the fierce competition surrounding the star ratings system will only intensify. Financial, legal, and reputational stakes are higher than ever—especially as Medicare Advantage becomes the dominant coverage model for American seniors.

Key questions loom going into the next plan cycle:

• Will CMS implement further recalibrations or freeze the current methodology pending the outcome of legal challenges?
• How will plan sponsors adapt their benefit offerings and contract negotiations to cope with increased volatility?
• Will greater transparency, stakeholder engagement, or Congressional action reshape the future of the star ratings program?

For now, all participants in the Medicare Advantage ecosystem face an era of heightened uncertainty. Success will depend not only on meeting existing benchmarks, but also on strategic resilience as CMS’s rulebook continues to shift.

Source: STAT News